Here's Why Investors Should Add Aflac Stock to Their Portfolio Now
Werte in diesem Artikel
Aflac Incorporated AFL is well-poised to grow on the back of a strong U.S. business, product launches and upgrades coupled with expanding cash reserves.AFL’s Zacks Rank & Price PerformanceAFL currently carries a Zacks Rank #2 (Buy).The stock has gained 30.1% in the past six months compared with the industry’s 33.1% growth. The Finance sector and the S&P 500 Composite have risen 10.1% and 14.2%, respectively, in the same time frame.Image Source: Zacks Investment ResearchTrend in EstimatesThe Zacks Consensus Estimate for AFL’s 2024 earnings is pegged at $7.27 per share, indicating growth of 16.7% from the prior-year figure. The consensus mark for 2025 earnings is pegged at $7.21 per share. The Zacks Consensus Estimate for 2024 earnings has been revised 6.4% upward in the past 30 days.Key DriversAflac's revenues are bolstered by strong sales in its U.S. and Japan segments, driven by strategic growth investments, robust persistency rates and enhanced productivity. The company designs and markets supplemental insurance products across both countries through its Japan and U.S. segments. Increased sales of these products are likely to boost its premiums in the days ahead, which are a key contributor to an insurer’s revenue growth.Aflac introduces new products and upgrades existing ones to address its customers' changing needs. In July 2024, it partnered with SKYGEN to enhance dental and vision benefits management, leveraging advanced technology and streamlined processes to boost customer satisfaction and product sales. AFL’s Japan unit launched Tsumitasu, which targets young and middle-aged customers. This launch drove the 12.3% increase in third-quarter sales. Upcoming cancer insurance product for spring 2025 should further support this metric.The company also integrates digital solutions into its offerings to align with the ongoing trend of digitization. Aflac’s significant investments in digital transformation have improved operational efficiencies and facilitated a shift to digital sales channels, which could continue to support strong profit margins in the days ahead. The expense ratio in the U.S. improved 260 basis points year over year in the third quarter.Aflac’s solid financial position, supported by a strong cash balance and substantial cash flow, is a key strength. As of Sept. 30, 2024, cash and cash equivalents surged 30.2% from the 2023-end level. In the nine months of 2024, Aflac generated $2.4 billion in operating cash flows. This financial stability enables the company to pursue growth initiatives and engage in prudent capital deployment through share repurchases and dividend payments.Other Stocks to ConsiderSome other top-ranked stocks in the insurance space are Kemper Corporation KMPR, CNO Financial Group, Inc. CNO and Primerica, Inc. PRI. Each stock presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Kemper’s earnings surpassed the Zacks Consensus Estimate in two of the last four quarters, met once and missed the other time, with an average surprise of 10.5%. The Zacks Consensus Estimate for KMPR’s 2024 earnings indicates an 824.3% year-over-year rise. Its revenues for 2024 are projected to be $4.6 billion. The consensus mark for KMPR’s earnings has moved 6.8% north in the past 30 days.CNO Financial’s earnings surpassed estimates in three of the last four quarters and missed once, with an average surprise of 24.5%. The Zacks Consensus Estimate for CNO’s 2024 earnings indicates a 20.7% year-over-year rise. Its revenues are projected to be $3.7 billion in 2024. The consensus mark for CNO’s 2024 earnings has moved 8.7% north in the past 30 days.Primerica’s earnings outpaced estimates in two of the trailing four quarters and missed twice, the average surprise being 4.9%. The Zacks Consensus Estimate for PRI’s 2024 earnings is pegged at $19.32 per share. Meanwhile, revenues are projected to be $3 billion for 2024. The consensus mark for PRI’s 2024 earnings has moved up 1% in the past 30 days.Free Today: Profiting from The Future’s Brightest Energy SourceThe demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CNO Financial Group, Inc. (CNO): Free Stock Analysis Report Aflac Incorporated (AFL): Free Stock Analysis Report Primerica, Inc. (PRI): Free Stock Analysis Report Kemper Corporation (KMPR): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Aflac
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Aflac Inc
Analysen zu Aflac Inc
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2018 | Aflac Equal Weight | Barclays Capital | |
03.07.2017 | Aflac Equal Weight | Barclays Capital | |
01.05.2017 | Aflac Underperform | RBC Capital Markets | |
02.02.2017 | Aflac Underperform | RBC Capital Markets | |
09.12.2016 | Aflac Underperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
16.05.2012 | Aflac outperform | RBC Capital Markets | |
14.05.2012 | Aflac overweight | Barclays Capital | |
27.04.2012 | Aflac sector outperform | Scotia Capital Markets | |
26.04.2012 | Aflac outperform | RBC Capital Markets | |
27.03.2012 | Aflac overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
21.03.2018 | Aflac Equal Weight | Barclays Capital | |
03.07.2017 | Aflac Equal Weight | Barclays Capital | |
10.05.2016 | Aflac Mkt Perform | FBR Capital | |
27.04.2016 | Aflac Neutral | UBS AG | |
27.04.2016 | Aflac Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
01.05.2017 | Aflac Underperform | RBC Capital Markets | |
02.02.2017 | Aflac Underperform | RBC Capital Markets | |
09.12.2016 | Aflac Underperform | RBC Capital Markets | |
09.01.2012 | Aflac sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen